Johnson & Johnson: Low Back Pain trials

The registry lists 20 Low Back Pain studies with Johnson & Johnson as lead sponsor. 0 are open to participants now and 11 have results posted.

Phase 2 4Phase 3 9Phase 4 5No phase 2(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Efficacy and Safety Study of Tramadol Hydrochloride-Paracetamol in Treatment of Moderate to Severe Acute Neck-Shoulder Pain and Low Back PainCompletedNCT01843660Phase 4Results posted
• An Efficacy and Safety Study of Fentanyl Transdermal Patch in Filipino Participants With Osteoarthritis and Chronic Low Back PainCompletedNCT01795898Phase 4Results posted
• An Efficacy and Safety Study of Transdermal Therapeutic System (TTS)-Fentanyl in Severe Chronic Low Back PainCompletedNCT01774903Phase 4Results posted
• An Efficacy and Safety Study for Tapentadol Extended Release (JNS024ER) in Chronic Pain ParticipantsCompletedNCT01124604Phase 2Results posted
• An Efficacy and Safety Study of Extended Release (ER) Tramadol Hydrochloride (HCl)/Acetaminophen in Participants With Chronic Low-Back PainCompletedNCT01112267Phase 3Results posted
• A Confirmatory Study of Fentanyl in Participants With Osteoarthritis or Low Back PainCompletedNCT01008618Phase 3Results posted
• NUCYNTA (Tapentadol Immediate Release) Versus Oxycodone Immediate Release in the Treatment of Acute Low Back PainCompletedNCT00986180Phase 3Results posted
• Study on the Safety and Effectiveness of Switching Between Two Forms of Tapentadol in Patients With Chronic Low Back PainCompletedNCT00594516Phase 3Results posted
• An Open-label Extension Study With Flexible Dosing of Extended-release (ER) Tapentadol (CG5503) to Treat Patients With Moderate to Severe Chronic PainCompletedNCT00487435Phase 3Results posted
• A Study to Evaluate the Effectiveness and Safety of Tapentadol (CG5503) Extended Release (ER) in Patients With Moderate to Severe Chronic Low Back PainCompletedNCT00449176Phase 3Results posted
• A Study to Evaluate Long-Term Safety of Multiple Doses of Tapentadol (CG5503) Prolonged-Release (PR) and Oxycodone Controlled-Release (CR) in Patients With Chronic PainCompletedNCT00361504Phase 3Results posted
• Facet Wedge Post Market StudyCompletedNCT02203448
• An Open-label Evaluation of Tapentadol Extended Release (ER) in Participants With Moderate to Severe Chronic Pain After Conversion From Hydrocodone, Oxycodone Controlled Release (CR), and/or Morphine Sustained Release (SR)WithdrawnNCT01631513Phase 4
• A Dose-ranging Study of the Safety and Effectiveness of JNJ-42160443 as add-on Treatment in Patients With Low Back PainTerminatedNCT00973024Phase 2
• Study on Impact of Fentanyl Matrix on Improvement of Pain and Functioning in Spinal Disorder-related PainCompletedNCT00797017
• An Exploratory Study of Tramadol Hydrochloride in Patients With Osteoarthritis of the Knee or Low Back PainCompletedNCT00752661Phase 2
• Safety, Effectiveness, and Impact on Quality of Life on Long-Term Administration of OROS Hydromorphone Slow-Release in Patients With Chronic Low Back PainCompletedNCT00411268Phase 3
• A Study on Efficacy (Effectiveness), Safety, and Impact on Quality of Life Measures of Dilaudid CR (Controlled Release);, Hydromorphone HCl in Patients With Chronic Low Back PainCompletedNCT00398788Phase 2
• A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic PainCompletedNCT00364546Phase 3
• A Study of the Effectiveness and Safety of Tramadol HCl/Acetaminophen Compared to Placebo in Treating Acute Low Back PainTerminatedNCT00210561Phase 4